Impact Factor
2.97
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
1.65
507 total citations
h5-index
19
h5 depth signal
Cited share
60.7%
195 of 321
Total citations
507
Citation footprint
Metric signal
1.81
External metric anchor
Self-citation
2.6%
13 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
1,099
India
149
Pakistan
136
United Kingdom
73
China
62
Citing Fields of Research
Cardiology
941
Vascular Disorders
126
Diabetes
119
Autonomic Function
70
Lipids
60
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
2,607
Articles tracked across the journal lifetime
Indexed publication set
321
195 cited publications
Last 12 months
410
34.2 publications/month
Open access share
7.3%
30 OA publications in the last year
Leading citing country
United States
1,099 citing publications
Leading citing field
Cardiology
941 citing publications
Latest tracked publication
20 October 2026
10 recent records available
Coverage & Indexing History
v7n1, Jan./Feb. 1999-
v7n1, Jan./Feb. 1999-
Active Coverage
Research Focus & Classification
Indexed Subjects
Cardiology
Broad Categories
Cardiology
Vascular Diseases
MeSH Descriptors
Cardiovascular Diseases
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1097/crd.0000000000001504
Open DOI
Tirzepatide for Obstructive Sleep Apnea: Trial Evidence, Cardiometabolic Effects, and Implications for Cardiovascular Practice
Obstructive sleep apnea affects approximately one billion adults worldwide and is associated with hypertension, atrial fibrillation, heart failure, and stroke. Obesity is its dominant reversible cause, yet positive airway pressure therap...
02
DOI 10.1097/crd.0000000000001491
Open DOI
Cell-Based Inflammatory Indices for Risk Stratification in Acute Myocardial Infarction: Current Evidence and Future Perspectives
Acute myocardial infarction (AMI) remains a leading cause of cardiovascular morbidity and mortality worldwide, despite substantial advances in reperfusion strategies and guideline-directed therapies. Increasing evidence highlights the pi...
03
DOI 10.1097/crd.0000000000001503
Open DOI
From Physiological to Potential Cardiovascular Maladaptation in Endurance Exercise
Emerging evidence suggests that the cardiovascular benefits of exercise may not increase indefinitely with training volume and intensity. As participation in ultraendurance sports continues to rise, concerns have been raised regarding th...
04
DOI 10.1097/crd.0000000000001498
Open DOI
Individualized Antiplatelet Therapy After Percutaneous Coronary Intervention for Acute Coronary Syndrome
Acute coronary syndrome requires effective antiplatelet therapy after percutaneous coronary intervention (PCI), while contemporary patients often present with overlapping ischemic and bleeding risks. This clinical complexity has shifted ...
05
DOI 10.1097/crd.0000000000001505
Open DOI
Social Isolation and Loneliness Across the Cardiovascular Disease Spectrum: A Narrative Review of Evidence, Mechanisms, and Clinical Implications
Social isolation is the objective paucity of social ties; loneliness is the subjective distress of relationships falling short of what one desires. Both are common, affecting roughly a quarter to a third of older adults, and both have ca...
06
DOI 10.1097/crd.0000000000001492
Open DOI
Extended Dual Antiplatelet Therapy Versus Aspirin Monotherapy After Drug-Eluting Stent Implantation
The optimal duration of dual antiplatelet therapy (DAPT) following drug-eluting stent implantation remains uncertain. We evaluated extended DAPT versus aspirin monotherapy in patients who completed approximately 12 months of uneventful D...
07
DOI 10.1097/crd.0000000000001496
Open DOI
Von Willebrand Factor Biomarkers in Prosthetic Valve Dysfunction
Imaging remains the foundation of prosthetic valve surveillance because it identifies valve morphology, lesion mechanism, and hemodynamic severity. However, acoustic shadowing, eccentric or multiple regurgitant jets, loading conditions, ...
08
DOI 10.1097/crd.0000000000001495
Open DOI
Perioperative Outcomes of Acute Normovolemic Hemodilution in Cardiac Surgery
Acute normovolemic hemodilution (ANH) is a blood conservation strategy used in cardiac surgery, but its efficacy in reducing allogeneic blood transfusion remains debated. This systematic review and meta-analysis updates the existing evid...
09
DOI 10.1097/crd.0000000000001486
Open DOI
Catheter-Directed Thrombolysis Plus Anticoagulation versus Anticoagulation Alone for Acute Intermediate-Risk Pulmonary Embolism: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Systemic anticoagulation is the standard initial therapy for intermediate-risk pulmonary embolism (PE) but fails to reverse right ventricular (RV) overload rapidly. While full-dose systemic thrombolysis accelerates RV recovery, it carrie...
10
DOI 10.1097/crd.0000000000001488
Open DOI
The Impact of Renin–Angiotensin System Inhibitors on Postoperative Outcomes Following Coronary Artery Bypass Grafting
Patients undergoing coronary artery bypass grafting (CABG) remain at high risk of major adverse cardiovascular events and death despite successful revascularization, and the role of renin–angiotensin system inhibitors (RASi), comprising ...
Bibliographical & Catalog Notes
Title from cover.
Imprint varies.
Print issues ceased with v. 28 (2020).
Also issued online.
19980205 Not printed on acid-free paper